Prostatype Genomics Statements
PG
Data from Prostatype Genomics`s earning releases including common size income statement and balance sheet.
Common size analysis evaluates financial statements by expressing each line item as a percentage of a base amount for that period.
Key Information:
Report currency :
SEK - Swedish krone
Last reporting period :
31 Dec, 2022
New report :
—
Reporting period :
Quarterly
Earnings release date:
—
Expected release date:
—
Prostatype Genomics Income Statement
B
M
SEK (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
0.304
177.3 %
100
—
0
0.304
—
100
0.728
239.3
3.168
1040.9
8.443
8.9 %
2774.4
-8.139
-6.5 %
-2674.4
-0.02
-6.7
—
0
-8.159
-2.2 %
-2681.07
—
0
-8.159
-2.2 %
-2681.07
-0.077
106.55
0.11
1278.9 %
100
—
0
—
—
0
1.378
1255.9
2.804
2554.9
7.751
5 %
7062.2
-7.642
-3.6 %
-6962.2
-0.342
-311.5
—
0
-7.984
-8 %
-7273.7
—
0
-7.984
-8 %
-7273.7
-0.09
88.444
0.008
-96.9 %
100
—
0
0.008
-96.9 %
100
0.728
9141.3
2.284
28691.5
7.381
27.3 %
92721.2
-7.373
-33.2 %
-92621.2
-0.016
-203.3
—
0
-7.389
-33 %
-92824.5
—
0
-7.389
-33 %
-92824.5
-0.155
47.528
0.261
Infinity %
100
—
0
0.261
-64.5 %
100
0.673
258.3
2.132
817.7
5.798
-10.4 %
2223.3
-5.537
3.4 %
-2123.3
-0.018
-7
—
0
-5.555
3.4 %
-2130.3
—
0
-5.555
3.4 %
-2130.3
-0.118
47.268
—
—
100
-0.735
0
0.735
72.4 %
0
0.611
0
2.991
0
6.469
59.2 %
0
-5.734
-57.7 %
0
-0.019
0
—
0
-5.753
-57.4 %
0
—
0
-5.753
-57.4 %
0
-0.103
55.729
—
-100 %
100
-0.426
0
0.426
-68.4 %
0
0.406
0
1.732
0
4.062
-46 %
0
-3.636
41.2 %
0
-0.02
0
—
0
-3.656
41.2 %
0
—
0
-3.656
41.2 %
0
-0.247
14.799
0.01
—
100
-1.338
-13381.8
1.348
—
13481.8
0.472
4717
3.258
32581.7
7.527
—
75270.8
-6.179
—
-61789
-0.042
-420.3
—
0
-6.221
—
-62209.3
—
0
-6.221
—
-62209.3
-0.42
14.799